Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

Value communications

- PMLiVE

Research Partnership appoints Tom Nolte

He takes up a role as director and head of business analytics, North America

- PMLiVE

Leveraging HCP transparency insights to drive future customer investments

EFPIA’s disclosure requirements present an opportunity to assess strategy and effectiveness

- PMLiVE

Takeda forms new women’s health and cancer company

Recruits former Medivation CMO Lynn Seely to lead Myovant Sciences

China drug medicine pharma prices

Cancer drugs “less affordable in low-income countries”

China and India are among those hit hardest by the rapidly escalating price of therapies

- PMLiVE

Roche launches Bluetooth coagulation testing system

New CoaguChek device can wirelessly transmit test data to a patient's clinic

- PMLiVE

Trial of AbbVie’s Rova-T disappoints at ASCO

But company says the modest trial data is “a good early sign” for lung cancer drug

- PMLiVE

Anke Buchta joins emotive

She becomes the agency’s creative director

- PMLiVE

DiCE Molecules adds Dr Richard Scheller to its board of directors

He currently serves as chief scientific officer at 23andMe

- PMLiVE

Explosive evolution

Companies are being forced to diversify and specialise their business models

- PMLiVE

AstraZeneca to develop Lynparza companion diagnostic

Will collaborate with Foundation Medicine on test for its ovarian cancer drug

- PMLiVE

Biosimilar trastuzumab comparable to brand, ASCO hears

Roche’s Herceptin matched in safety and efficacy by Mylan and Biocon’s breast cancer drug

Roche Basel Switzerland

Roche’s Tecentriq works as first-line bladder cancer therapy

New trial data presented at ASCO supports wider use of the drug

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links